Je Craig And Associates Pc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 3383 S Lapeer Rd, Metamora, MI 48455 Phone: 810-406-1660 Fax: 248-970-0210 |
R & H Behavior Consulting Llc Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 2855 Galway Bay Dr, Metamora, MI 48455 Phone: 248-672-9521 |
Roger C. Gietzen, M.d., P.c. Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 3630b Thornville Rd, Metamora, MI 48455 Phone: 586-838-0404 |
The Centre Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3562 S Lapeer Rd, Suite F, Metamora, MI 48455 Phone: 810-678-8898 Fax: 810-678-8808 |
News Archive
New research demonstrates that the six-step hand-hygiene technique recommended by the World Health Organization is superior to a three-step method suggested by the U.S. Centers for Disease Control and Prevention in reducing bacteria on healthcare workers' hands. The study was published online today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, and Ascentage Pharma Group Corporation, Ltd. ("Ascentage Pharma") announced today that they have formed a strategic alliance to research, develop and commercialize best-in-class targeted cancer therapeutics focusing on programmed cell death, or apoptosis. The alliance will leverage Ascentage Pharma's expertise in structure-based small molecule design, lead optimization and preclinical development with 3SBio's proven drug development and commercialization capabilities in China.
As thousands of Americans await a life-saving kidney or liver transplant, medical teams are paying close attention to another organ: their hearts. This month the American Heart Association attempts to bring harmony to the varied cardiac evaluation policies created at U.S. hospitals that assess a patient's overall health before transplant surgery.
A new technique that makes blood clots optically clear is allowing researchers to use powerful optical microscopy techniques to study the 3D structure of dangerous clots for the first time.
Boehringer Ingelheim has today announced that it has updated the US prescribing information for Pradaxa (dabigatran etexilate) in alignment with the US Food and Drug Administration (FDA) to affirm that "Pradaxa 150mg twice daily was superior in reducing ischemic and hemorrhagic strokes relative to warfarin."
› Verified 3 days ago